Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab

The introduction of a third‐dose vaccination along with new variants of concern raises questions regarding serology and T‐cell responses in patients with multiple sclerosis (pwMS) treated with B‐cell depletion who develop attenuated humoral response to vaccines. The aim of this study was to longitud...

Descripción completa

Detalles Bibliográficos
Autores principales: Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082479/
https://www.ncbi.nlm.nih.gov/pubmed/35243687
http://dx.doi.org/10.1002/ana.26343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082479/
https://www.ncbi.nlm.nih.gov/pubmed/35243687
http://dx.doi.org/10.1002/ana.26343

Ejemplares similares